68 Gynecologic and breast cancer patient experiences with scalp cooling to reduce alopecia
Objectives: Chemotherapy-induced alopecia represents a significant patient concern. The DigniCapTM Scalp Cooling Device is not covered by health insurance and patients pay out of pocket for each chemotherapy infusion. Previous reports comprised of heterogeneous populations with mixed results have no...
Saved in:
Main Authors: | Sujata E. Tewari (Author), Colleen McGuire (Author), Krishnansu S. Tewari (Author), Kiran H. Clair (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: A pilot project
by: Cristina Mitric, et al.
Published: (2021) -
Scalp cooling to prevent chemotherapy-induced alopecia,
by: Giselle de Barros Silva, et al.
Published: (2020) -
[Translated article] Chemotherapy, Alopecia, and Scalp Cooling Systems
by: D. Amarillo, et al.
Published: (2022) -
Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
by: Portia Lagmay-Fuentes, et al.
Published: (2024) -
Alopecia, quimioterapia y gorras de frío o «scalp cooling system»
by: D. Amarillo, et al.
Published: (2022)